Direct Lytic Agents: Novel, Rapidly Acting Potential Antimicrobial Treatment Modalities for Systemic Use in the Era of Rising Antibiotic Resistance

Direct lytic agents (DLAs) are novel antimicrobial compounds with unique mechanisms of action based on rapid cell wall destabilization and bacteriolysis. DLAs include two classes of purified polypeptides—lysins (peptidoglycan hydrolase enzymes) and amurins (outer membrane targeting peptides). Their...

Descripción completa

Detalles Bibliográficos
Autores principales: Schuch, Raymond, Cassino, Cara, Vila-Farres, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928733/
https://www.ncbi.nlm.nih.gov/pubmed/35308352
http://dx.doi.org/10.3389/fmicb.2022.841905

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928733/
https://www.ncbi.nlm.nih.gov/pubmed/35308352
http://dx.doi.org/10.3389/fmicb.2022.841905

Ejemplares similares